logo
Cemtrex Reports Second Quarter Fiscal Year 2025 Financial Results

Cemtrex Reports Second Quarter Fiscal Year 2025 Financial Results

Globe and Mail15-05-2025

Brooklyn, NY, May 15, 2025 (GLOBE NEWSWIRE) -- - Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, has reported its financial and operational results for the fiscal second quarter ended March 31, 2024.
Key Highlights for Second Fiscal Quarter 2025
Revenue increased 59% to $27.3 million, compared to revenue in the prior year quarter of $17.2 million.
Operating Income totaled $4.6 million, compared to an operating loss of $1 million in Q2 FY 2024.
Net Income for the period was $8.4 million, compared to a net loss of $1.5 million in Q2 FY 2024.
Gross profit margin increased to 45%, up from 40% in the prior year period.
Stockholders equity rose to $6.4 million, up from $4.7 million at September 30 th 2024.
Management Commentary
Cemtrex Chairman and CEO, Saagar Govil, commented on the results: 'We are extremely pleased with our strong second quarter performance, which reflects our team's sharp focus on execution and margin improvement. Both operating segments contributed to robust revenue growth, and we delivered a return to profitability on both an operating and net income basis. The improvement in gross margins, combined with disciplined expense management, enabled us to post over $8 million in net income this quarter. We believe this result marks an inflection point for Cemtrex.
'At Vicon, our Security segment, we benefited from the initial shipments of a record $10.4 million order and from the ramp-up of our new NEXT Modular Sensor System, which is now in full production. Our efforts to expand our presence in international markets are also beginning to show progress, with recent STQC certification in India positioning us for long-term growth in that region. Meanwhile, our Industrial Services segment, AIS, delivered solid 13% year-over-year growth and continues to execute well on large infrastructure and industrial projects.'
'We remain laser-focused on delivering shareholder value through improved profitability, strategic innovation, and operational discipline. With a strengthening balance sheet and a growing backlog, we believe we are positioned to sustain momentum through the second half of the fiscal year, and remain optimistic that fiscal 2025 financial performance will surpass fiscal 2024.'
Segment Highlights:
Vicon Industries:
Revenue grew 110% year-over-year to $17.0 million, driven by execution of a large government order and increased demand for AI-enhanced security solutions.
Gross margin improved to 52% from 51% in the prior year quarter.
Operating income for the segment totaled $4.3 million, compared to a loss of $0.7 million a year ago.
Advanced Industrial Services:
Revenue increased 13% to $10.3 million, up from $9.1 million in the prior year period.
Gross profit grew to $3.4 million, with gross margin improving to 33%.
Operating income rose to $0.9 million from $0.7 million in Q2 FY2024.
Metric Q2 FY2025 Q2 FY2024 % Change
Revenue $27.3M $17.2M +59%
Gross Profit $12.2M $6.9M +75%
Gross Margin 45% 40% +500bps
Operating Income $4.6M ($1.0M) N/A
Net Income to CETX Shareholders $8.4M ($1.5M) N/A
EPS (Basic & Diluted) $4.10 ($3,054.05) N/A
As of March 31, 2025, cash and cash equivalents were $4.5 million, and total assets were $46.2 million. Inventories decreased to $6.1 million at March 31, 2025, from $7.0 million at September 30, 2024. Stockholders' equity improved to $6.4 million, exceeding Nasdaq's minimum continued listing standards.
About Cemtrex
Cemtrex, Inc. (Nasdaq: CETX) is a diversified technology company operating in the Security and Industrial sectors. Its Security segment, led by Vicon Industries, provides advanced video management software, high-performance security cameras, and integrated surveillance solutions for enterprise, government, and critical infrastructure. The Industrial segment, through Advanced Industrial Services (AIS), delivers expert rigging, millwrighting, process piping, and equipment installation services to manufacturers nationwide. With a focus on innovation, execution, and strategic growth, Cemtrex is committed to enhancing safety, efficiency, and value for its customers and shareholders.
For more information visit www.cemtrex.com.
Forward-Looking Statements
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the closing of the offering, gross proceeds from the offering, our new product offerings, expected use of proceeds, or any proposed fundraising activities. These forward-looking statements are based on management's current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by such forward looking statements. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. These risks and uncertainties are discussed under the heading 'Risk Factors' contained in our Form 10-K filed with the Securities and Exchange Commission. All information in this press release is as of the date of the release and we undertake no duty to update this information unless required by law.
(Unaudited)
March 31, September 30,
2025 2024
Assets
Current assets
Cash and cash equivalents $ 4,538,405 $ 3,897,511
Restricted cash 1,527,628 1,522,881
Trade receivables, net 12,715,992 11,159,676
Trade receivables, net - related party 550,613 685,788
Inventory, net 6,136,765 6,988,529
Contract assets, net 1,156,620 985,207
Prepaid expenses and other current assets 2,026,088 1,456,687
Total current assets 28,652,111 26,696,279
Property and equipment, net 9,813,887 9,133,578
Right-of-use operating lease assets 1,676,614 1,933,378
Royalties receivable, net - related party 272,423 456,611
Goodwill 3,708,347 3,708,347
Other 2,113,768 2,187,265
Total Assets $ 46,237,150 $ 44,115,458
Liabilities & Stockholders' Equity
Current liabilities
Accounts payable $ 4,001,843 $ 4,520,173
Sales tax payable 3,970 73,024
Revolving line of credit 2,867,425 3,125,011
Current maturities of long-term liabilities 9,301,045 4,732,377
Operating lease liabilities - short-term 829,644 832,823
Deposits from customers 182,855 408,415
Accrued expenses 2,764,172 1,393,902
Accrued payable on inventory in transit 242,303 640,450
Contract liabilities 1,924,425 1,254,204
Deferred revenue 1,179,536 1,297,616
Accrued income taxes 277,763 314,827
Total current liabilities 23,574,981 18,592,822
Long-term liabilities
Long-term debt 9,492,824 13,270,178
Long-term operating lease liabilities 902,223 1,159,204
Other long-term liabilities 282,200 274,957
Deferred Revenue - long-term 509,882 658,019
Warrant liabilities 4,747,468 5,199,436
Total long-term liabilities 15,934,597 20,561,794
Total liabilities 39,509,578 39,154,616
Commitments and contingencies - -
Stockholders' equity
Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 3,000,000 shares authorized, 2,579,994 shares issued and 2,515,894 shares outstanding as of March 31, 2025 and 2,456,827 shares issued and 2,392,727 shares outstanding as of September 30, 2024 (liquidation value of $10 per share) 2,580 2,457
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at March 31, 2025 and September 30, 2024 50 50
Common stock, $0.001 par value, 70,000,000 shares authorized, 1,784,581 shares issued and outstanding at March 31, 2025 and 14,176 shares issued and outstanding at September 30, 2024 1,785 14
Additional paid-in capital 95,879,333 73,262,536
Accumulated deficit (91,726,811) (71,355,386)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at March 31, 2025, and September 30, 2024 (148,291) (148,291)
Accumulated other comprehensive income 2,394,376 2,949,297
Total Cemtrex stockholders' equity 6,403,022 4,710,677
Non-controlling interest 324,550 250,165
Total liabilities and stockholders' equity $ 46,237,150 $ 44,115,458
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(Unaudited)
For the three months ended For the six months ended
March 31, 2025 March 31, 2024 March 31, 2025 March 31, 2024
Revenues $ 27,250,269 $ 17,159,595 $ 40,990,168 $ 34,037,761
Cost of revenues 15,084,814 10,220,179 23,122,777 20,015,946
Gross profit 12,165,455 6,939,416 17,867,391 14,021,815
Operating expenses
General and administrative 6,770,742 7,020,157 13,864,031 13,992,123
Research and development 777,889 951,400 1,667,972 1,800,205
Total operating expenses 7,548,631 7,971,557 15,532,003 15,792,328
Operating income/(loss) 4,616,824 (1,032,141) 2,335,388 (1,770,513)
Other (expense)/income
Other income, net (150,165) 144,765 (115,192) 223,176
Interest expense (452,998) (592,804) (936,911) (1,176,487)
Loss on exercise of warrant liabilities - - (15,796,105) -
Changes in fair value of warrant liability 4,707,374 - (5,312,838) -
Total other income/(expense), net 4,104,211 (448,039) (22,161,046) (953,311)
Net income/(loss) before income taxes 8,721,035 (1,480,180) (19,825,658) (2,723,824)
Income tax expense 110,525 100,004 231,063 170,755
Income/(loss) from Continuing operations 8,610,510 (1,580,184) (20,056,721) (2,894,579)
Income/(loss) from discontinued operations, net of tax 26,969 10,463 (240,319) 20,955
Net income/(loss) 8,637,479 (1,569,721) (20,297,040) (2,873,624)
Less net income/(loss) in noncontrolling interest 254,537 (96,510) 74,385 (192,919)
Net income/(loss) attributable to Cemtrex, Inc. stockholders $ 8,382,942 $ (1,473,211) $ (20,371,425) $ (2,680,705)
Income/(loss) per share - Basic & Diluted
Continuing Operations $ 4.10 $ (3,054.05) $ (10.62) $ (5,497.36)
Discontinued Operations $ 0.01 $ 20.80 $ (0.13) $ 41.83
Weighted Average Number of Shares-Basic & Diluted 2,032,744 503 1,897,797 501
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(Unaudited)
For the six months ended
March 31,
2025 2024
Cash Flows from Operating Activities
Net loss $ (20,297,040) $ (2,873,624)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization 648,109 673,190
Loss on disposal of property and equipment 19,668 -
Noncash lease expense 461,490 389,125
Goodwill impairment - -
Bad debt expense 10,572 35,213
Contract modification - related party 280,545 -
Share-based compensation 7,183 15,116
Income tax expense - (96,750)
Shares issued to pay for services - 40,000
Accrued interest on notes payable 530,404 657,355
Non-cash royalty income (71,464) (26,564)
Amortization of original issue discounts on notes payable 16,667 -
Loan origination costs 5,000 36,267
Loss on exercise of warrant liabilities 15,796,105 -
Changes in fair value of warrant liability 5,312,838 -
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:
Trade receivables (1,536,888) (2,317,074)
Trade receivables - related party 66,057 (178,980)
Inventory 851,764 1,341,472
Contract assets (171,413) (240,478)
Prepaid expenses and other current assets (569,401) 482,853
Other assets 173,497 (225,853)
Accounts payable (518,330) (455,315)
Accounts payable - related party - 408
Sales tax payable (69,054) 1,658
Operating lease liabilities (464,886) (388,516)
Deposits from customers (225,560) 150,274
Accrued expenses 972,123 (108,311)
Contract liabilities 670,221 919,090
Deferred revenue (266,217) (252,109)
Income taxes payable (38,617) (146,422)
Other liabilities 7,243 (184,261)
Net cash provided/(used) by operating activities 1,600,616 (2,752,236)
Cash Flows from Investing Activities
Purchase of property and equipment (1,359,963) (355,308)
Proceeds from sale of property and equipment 13,511 -
Royalties on related party revenues 10,000 -
Investment in MasterpieceVR (100,000) (100,000)
Net cash used by investing activities (1,436,452) (455,308)
Cash Flows from Financing Activities
Proceeds on revolving line of credit 18,925,223 19,360,672
Payments on revolving line of credit (19,182,809) (15,413,971)
Payments on debt (240,510) (2,634,545)
Payments on Paycheck Protection Program Loans (20,247) (20,242)
Proceeds on bank loans - 28,331
Proceeds from notes payable 500,000 -
Proceeds from warrant exercises 1,050,597 -
Purchases of treasury stock - (69,705)
Net cash provided by financing activities 1,032,254 1,250,540
Effect of currency translation (550,777) (304,022)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 1,196,418 (1,957,004)
Cash, cash equivalents, and restricted cash at beginning of period 5,420,392 6,349,562
Cash, cash equivalents, and restricted cash at end of period $ 6,066,033 $ 4,088,536
Cemtrex, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Continued)
(Unaudited)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts
From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts

Globe and Mail

time17 minutes ago

  • Globe and Mail

From Exploration to Execution: New Gold Player Emerges in One of Canada's Premier Mining Districts

NEW YORK , June 23, 2025 /CNW/ -- Gold's meteoric rally, fueled by waning confidence in U.S. fiscal policy and soaring inflation, has not only pushed prices past the historic US$3,300 per ounce mark in early 2025 but also opened the door to even more ambitious forecasts. Some analysts now predict a climb to US$4,000 within the next 12 to 18 months. With this in mind, gold-focused equities and Canadian gold producers are gaining renewed attention for offering high leverage to rising bullion prices within a stable jurisdiction known for quality deposits and operational reliability. Among these, LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) ( LaFleur Profile) stands out with its fully permitted gold mill situated in Canada's most prolific gold-producing region — a combination that aligns perfectly with today's market demands, providing investors both near-term production potential and exposure to the upside of surging gold. LaFleur Minerals is laser focused on positioning itself as a strong contender in a space known for quality gold-mining operations, including Barrick Mining Corporation (NYSE:B) (TSX:ABX), Royal Gold (NASDAQ: RGLD), Nicola Mining (TSXV: NIM) (OTCQB: HUSIF ) and ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF). Gold-focused stocks, particularly those tied to Canadian producers, are drawing fresh interest for their strong leverage to rising gold prices and their presence in a secure, resource-rich jurisdiction known for dependable operations. LaFleur Minerals is an emerging near-term producer strategically positioned in Québec's prolific Abitibi Gold Belt — Canada's largest gold-producing region. The company is gaining attention in the junior gold space due to its Swanson Gold Project, which hosts the advanced resource-stage Swanson gold deposit. LaFleur Minerals is on the cusp of transforming its operational footprint with the restart of the fully refurbished and permitted Beacon Gold Mill and producing gold at Canadian dollar costs. Click here to view the custom infographic of the LaFleur Minerals editorial. A Dramatic Rise Driven by declining trust in U.S. fiscal policy and rising inflation, gold's rapid ascent has propelled prices up to US$3,200 per ounce level as of early 2025, and many believe this is just the beginning. Projections now suggest gold could reach US$4,000 soon. The dramatic rise from US$2,500 to US$3,000 in only 210 days, marking the fastest increase of its kind on record ( highlights the strength and momentum behind the ongoing gold rally. Leading financial institutions are raising their gold price projections, with Goldman Sachs forecasting a rise to US$3,700 by the end of 2025 and reaching US$4,000 by mid-2026 ( JPMorgan is also predicting gold will hit the US$4,000 mark, attributing this expected increase to strong central bank demand, which is averaging approximately 710 tonnes in net purchases each quarter ( With this in mind, gold-focused stocks — particularly those tied to Canadian producers — are drawing fresh interest for their strong leverage to rising gold prices and their presence in a secure, resource-rich jurisdiction known for dependable operations. Standing out among these producers is LaFleur Minerals, which owns the fully permitted and recently refurbished Beacon Gold Mill located in Canada's most productive gold region and mining town. This strategic positioning offers investors a compelling mix of near-term production readiness and exposure to the continued upside of a bullish gold market. From Explorer to Producer LaFleur Minerals is an emerging near-term producer strategically positioned in Québec's prolific Abitibi Gold Belt. With 100%-owned assets and a focus on near-term cash flow, LaFleur is advancing its flagship Swanson Gold Deposit, an advanced resource-stage property with more than 36,000 meters of historical drilling and strong development potential. In addition, a key component to LaFleur's near-term production strategy is its fully permitted and recently acquired Beacon Gold Mill. The mill is located just 50 kilometers from the Swanson Project. Purchased in 2024 following approximately US$20 million in upgrades by its previous owner, the Beacon Mill has a processing capacity of more than 750 tonnes per day and is being prepared for restart by the end of this year. The mill positions LaFleur to not only process its own ore from its Swanson Gold Project but also generate revenue through custom milling of nearby gold deposits, which the region is flush with. This vertical integration marks a significant shift for LaFleur, from an explorer to a near-term gold producer in a tier 1 mining jurisdiction with considerable upside potential. Drilling and Permitting LaFleur Minerals is quickly gaining attention in the junior gold space due to its Swanson Gold Project. The Swanson deposit hosts an NI 43–101-compliant resource of 2.113 million tonnes at 1.8 g/t gold, containing 123,400 ounces in the Indicated category, plus 872,000 tonnes at 2.3 g/t gold for 64,500 ounces in the Inferred category ( These figures represent an 8% increase in Indicated ounces and a remarkable 626% increase in Inferred ounces compared to past estimates, highlighting the property's compelling upside. Looking ahead, LaFleur will launch a significant diamond drilling campaign in Q3 2025, comprising a minimum of 5,000 meters of diamond drilling at several promising gold targets at the Swanson Gold Project with the goal to increase resources to more than one million ounces of gold. In parallel, LaFleur has commenced permitting for a substantial 100,000–tonne surface bulk sample from the Swanson gold deposit, averaging an estimated grade of 1.89 g/t gold, which can be concentrated to higher grade for shipping and milling economics, equating to roughly 6,350 ounces, or about 3% of the current resource ( With samples being processed at the nearby Beacon Mill, this initiative is aimed at generating early cash flow, delivering vital metallurgical data and advancing the project's economic evaluation ( Near–Term Gold Production LaFleur Minerals is on the cusp of transforming its operational footprint with the restart of the fully refurbished and permitted Beacon Gold Mill near Val–d'Or, Québec. Purchased from Monarch Mining under Canada's CCAA process in late 2024, this strategically located processing plant differentiates LaFleur by allowing the company to process its own Swanson Gold Project material and deliver custom milling services to nearby deposits ( The Beacon Mill is nestled within the Abitibi Gold Belt in Val-d'Or, Quebec , which hosts more than 100 historical and active mines in close proximity ( The mill's location positions it perfectly for efficient ore transport, enabling LaFleur to fast–track bulk sample processing and full-scale ore milling, which is especially vital as the company advances toward bulk sample permitting and eventual mining at Swanson , with intent to generate meaningful cash flow by year-end into 2026. Acquired through an arm's length asset purchase agreement, the transaction was financed with CA$250,000 in cash and CA$850,000 in equity, with court approval received in October 2024 . Monarch had suspended operations in September 2022 , when gold traded in the CA$1,800/ounce range, maintaining the mill in care and maintenance after contributing CA$20 million in restoration. The facility features a Merrill-Crowe cyanidation circuit, a 27.5 m × 69 m processing building, extensive water and tailings basins, and robust electrics driven by a 4,000 kVA transformer. In early 2025, LaFleur initiated a detailed restart program using ABF Mines and environmental consultants to conduct site inspections, develop a parts inventory and complete geotechnical and tailings storage facility assessments; the company plans to return the mill to full operation by early 2026 ( Restart costs are expected to be in the CA$5–6 million range over a six- to eight–month period, with an aim to begin processing mineralized content by the end of 2025 and generating initial annual production of up to 30,000 ounces ( This path to production highlights the low-risk, low-restart cost factor and immense upside potential as the LaFleur pivots years ahead of other players in the region. The timing could not be better. With gold prices reaching US$3,200 /oz, the economics of near–term production are compelling. This asset gives LaFleur a competitive head start, potentially placing it at least five years ahead of peers still in exploration mode. The Beacon Mill metamorphoses LaFleur into a producer, offering a pathway to revenue, regional cooperation through custom milling agreements and derisked operational scaling. In addition to processing bulk sample material, the mill's capacity opens doors to third-party contracts. This potential stream of incremental revenue would not only improve cash flow but also enhance relationships with nearby exploration companies and communities. From an investor's standpoint, the strategic value of Beacon seems clear. The facility offers economies of scale, redevelopment of an existing asset and immediate scalability without the typical delays associated with permitting greenfield mill sites. It also complements the Swanson resource. The interconnection of project and mill underscores a vertically integrated model that enhances project economics and puts the company on a production trajectory in a tier 1 jurisdiction. In addition, having a fully permitted Beacon Gold Mill offers LaFleur an amazing opportunity to expand the Beacon Gold Mill to higher capacity using cash flow from current gold production without having to go through the permitting processes that any new mill would require, involving three to five years in permitting processes and costs. Integrated Strategy, Key Transition LaFleur's clear timeline — from asset closing in October 2024 to restart planning and permitting in Q1–Q2 2025, toward anticipated production in early 2026 — reflects a highly structured execution strategy that positions the company as a potential near-term gold producer with robust upside. LaFleur's methodical approach aligns with its broader strategy: blend resource growth via systematic drilling with infrastructure-led delivery through an adjacent mill. Ongoing exploration, including airborne geophysics, IP surveys and geochemical sampling, has also identified more than 50 new drill targets, laying groundwork for resource expansion. This integrated strategy positions LaFleur to make the key transition from explorer to producer. By mid–2025, the company aims to process the Swanson bulk sample at Beacon and commence mill restart, generating initial revenues and funding further development. Once full-scale operations begin, production could yield over 30,000–40,000 ounces per annum, given the mill's capacity ( In today's gold market, which is marked by elevated prices and investor focus on low-risk jurisdictions, LaFleur stands out for its balance of scalability, infrastructure and sustainability. Its dual promise of exploration upside and near-term value capture via bulk sampling and mill access makes it appealing to investors seeking exposure to a responsibly managed and strategically advanced gold project. Quality Gold Operations As gold prices continue their historic rally and investor interest intensifies, leading companies across the mining sector are making bold moves to capitalize on favorable market conditions. From global producers ramping up output to royalty firms securing high-potential assets and juniors advancing exploration and development, these gold-focused entities are strategically positioned to deliver value. Barrick Mining Corporation (NYSE:B) (TSX:ABX) is advancing its global portfolio of gold assets ( The company reported that its gold production of 758,000 ounces was "at the top end of guidance," with the "the average realized gold price for the quarter of $2,898 per ounce, up 40% from the prior year, support[ing] stronger margins despite ongoing expansion work at Pueblo Viejo and planned maintenance at Nevada Gold Mines — initiatives that will position both mines for a stronger output next quarter and the rest of the year." In addition, Barrick president and CEO Mark Bristow noted that Barrick has significantly advanced several key growth projects. Royal Gold (NASDAQ: RGLD) is reporting that its wholly owned subsidiary, RGLD Gold AG, has entered into a gold purchase agreement and a separate net smelter return royalty agreement for all metals produced from the Warintza Project in southeastern Ecuador for total cash consideration of US$200 million ( Warintza is indirectly owned and operated by Solaris Resources Inc. The strategic acquisition of the stream and royalty will provide Royal Gold shareholders exposure to a world-class resource with long life and large-scale production potential as well as a project with an accelerated development timeline operated by an experienced team and significant long-term growth potential from large areas of interest. Nicola Mining (TSXV: NIM) (OTCQB: HUSIF) has received a multiyear, area-based exploration permit that allows the company to conduct extensive exploration on its wholly owned Treasure Mountain Silver Project, a fully permitted silver mine in British Columbia ( The company also has received a 10-year mining lease extension for Treasure Mountain under its M-239 permit. The extension, which is valid through April 26, 2032 , and receipt of the MYAB permit positions the company to leverage both mining and exploration options. Treasure Mountain consists of an historic underground silver mine with a resource estimate in accordance with CIM definition standards and exploration upside to the north and west of the historic mine. ESGold (CSE: ESAU) (OTCQB: ESAUF) a fully permitted, preproduction gold and silver company, is reporting that with concentrate testing underway, Humphrey Spirals installed, and major data releases imminent, the company is entering a pivotal month of execution ( With construction now steadily advancing, the company confirms the successful installation of the Humphrey Spirals, which is a core component of the gravity separation circuit that will be used to process historical tailings and recover gold, silver and mica concentrate at its Montauban location. "This milestone establishes the foundation for the plant's initial production throughput, with equipment capable of supporting up to 1,000 tonnes per day (TPD)," the company stated. These developments reflect the strength and adaptability of the gold mining sector as companies at every stage and level — from exploration to production — take decisive steps to expand resources, enhance operational capacity and position themselves for long-term growth. With gold prices holding near record highs, these strategic advancements underscore the sector's readiness to capitalize on the current market and deliver continued value to shareholders. For more information about LaFleur Minerals, visit LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) About NetworkNewsWire NetworkNewsWire ("NNW") is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge. For more information, please visit Please view full terms of use and disclaimers on the NNW website applicable to all content provided by NNW, wherever published or re-published: NetworkNewsWire is powered by IBN DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security. The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer's filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer's securities, including, but not limited to, the complete loss of your investment. NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Samsara Announces 2025 North America Customer Advisory Board to Accelerate AI-Powered Safety and Efficiency Breakthroughs
Samsara Announces 2025 North America Customer Advisory Board to Accelerate AI-Powered Safety and Efficiency Breakthroughs

National Post

time17 minutes ago

  • National Post

Samsara Announces 2025 North America Customer Advisory Board to Accelerate AI-Powered Safety and Efficiency Breakthroughs

Article content Members play a pivotal role in shaping Samsara solutions; meeting to be held today at the premier event for physical operations, Samsara Beyond Article content SAN DIEGO — Samsara Inc. ('Samsara') (NYSE: IOT), the pioneer of the Connected Operations ® Platform, today announced its 2025 North America Customer Advisory Board. Its members are at the forefront of the world's most complex operations, managing vast frontline workforces and asset portfolios, and are responsible for significant economic value. Recognizing the transformative impact of Samsara's AI-powered platform, these leaders have joined forces to help shape Samsara's product roadmap and to exchange insights for safer, more efficient, and sustainable operations for all. Article content 'I've seen firsthand the impact Samsara's platform has made on the industry, and I'm excited to play a role in what's to come,' said Jeff Wright, Vice President of Transportation at Quikrete. 'At Quikrete, we manage complex operations that greatly benefit from Samsara's real-time data. With AI's potential only growing in operations, this is an important moment to partner and drive innovation.' Article content The distinguished members of Samsara's 2025 North America Customer Advisory Board include leaders from organizations such as: Article content ArcBest, Don Davis, Vice President, Fleet Services Artera, Adam Lanier, Chief Safety Officer AWP Safety, Jarrod Wachter, Chief Operating Officer BNSF Railway, Matthew Igoe, Executive Vice President, Operations DHL Express, Fred Matthews, Senior Project Manager, Safety Programs DHL Supply Chain, Jennifer Miller, Vice President, Integrated Transportation Estes, Todd Florence, Chief Information Officer Ferrellgas, Tamria Zertuche, President and Chief Executive Officer First Student, Sean McCormack, Chief Information Officer Frontier Communications, Doug Spurlin, Senior Director, Operations Liberty Energy, Michael Tuomi, Director, HSE and Training MacAllister, Bill Dollard, Director, Corporate Fleet Martin Marietta, Greg Lahrman, Vice President, Enterprise Excellence Maxim Crane Works, Dennis Collins, Vice President, Operations Mohawk Industries, Andy Yearout, Senior Vice President, Supply Chain NiSource, Bill Jefferson, Chief Operations Officer Nutrien Ag Solutions, Adam Lorenz, Senior Director, Fleet and Procurement Operations Performance Food Group, Thomas Olitsky, Vice President, Safety Pike, James Banner, Senior Vice President, Administration and Safety Primoris, Eric Amlee, Vice President, Fleet Operations PS Logistics, Mauricio Paredes, Vice President, Technology Quikrete, Jeff Wright, Vice President, Transportation Republic Services, Brett Rogers, Vice President, Operations Technology Saia, Rohit Lal, Executive Vice President and Chief Information Officer Southeastern Freight Lines, Kerry Stritt, Vice President, Fleet Services Southern California Edison, Karan Kumar, Director, Transportation Services Sysco, Kevin Thomas, Vice President, Global EHSS and Asset Protection Tyson Foods, Phil Vanhook, Managing Director, Transportation Operations UNFI, Tehzin Chadwick, Senior Vice President, Safety UniFirst, Matt Croatti, Senior Vice President, Operations Univar Solutions, Rob McRae, Vice President, Transportation USIC, Tom Karnowski, Vice President, EHS XPO, Greg Pawelski, Vice President, Health and Safety Article content Samsara's platform is advanced by the direct input of its Customer Advisory Board, ensuring its products meet the evolving needs of physical operations. Leaders' insights have shaped innovations like Recognition, a feature that uses AI insights and real-time driver data to identify and celebrate outcomes like safe driving streaks and consistent compliance with regulations. In addition, they've influenced the Asset Tag, a small ruggedized tracker that helps customers find lost or stolen assets, reduce downtime, and streamline inventory management. Article content 'Being on Samsara's Customer Advisory Board has been incredibly valuable because we get to collaborate with other industry leaders and quickly see the results of our product feedback,' said James Banner, Senior Vice President of Administration and Safety at Pike. 'It's a unique opportunity to shape products that transform the way we operate. The Asset Tag is a prime example: we advised on use cases and the product has now reduced theft and improved efficiency for Pike and many others.' Article content Samsara's commitment to building market-leading technology and fostering a collaborative community is foundational to its mission. Its Customer Advisory Board is just one example that demonstrates this, others include Samsara User Groups, Samsara Spark, and Samsara Beyond. Samsara's forums create a space where the industry can connect, share their most pressing challenges, exchange ideas, and spark innovation. These moments drive real-world outcomes and operational excellence. Another popular program, Samsara Professional Credentials, celebrates the expertise of individuals who complete tailored learning experiences through the Samsara Academy. Samsara is proud to help the industry solve complex challenges with technology and community. Article content 'With all the changes AI is bringing to physical operations, the partnership between industry leaders and technology innovators has never been more important,' said Kiren Sekar, Chief Product Officer at Samsara. 'Our advisory board isn't just about adapting to change, but actively shaping the future of this industry and making a lasting impact, together.' Article content Samsara (NYSE: IOT) is the pioneer of the Connected Operations ® Platform, which enables organizations that depend on physical operations to harness Internet of Things (IoT) data to develop actionable insights and improve their operations. With tens of thousands of customers across North America and Europe, Samsara is a proud technology partner to the people who keep our global economy running, including the world's leading organizations across construction, transportation and warehousing, field services, manufacturing, retail, logistics, and the public sector. The company's mission is to increase the safety, efficiency, and sustainability of the operations that power the global economy. Article content Article content Article content

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer

Globe and Mail

time18 minutes ago

  • Globe and Mail

Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer

NEEDHAM, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Charles Schoch as Chief Financial Officer (CFO). Mr. Schoch, who has served as interim CFO of Candel since January 2024, will transition to the CFO role permanently, effective immediately. 'Charles has demonstrated exceptional financial and organizational leadership during his tenure as interim CFO,' said Paul Peter Tak, M.D., Ph.D., FMedSci, President and Chief Executive Officer of Candel. 'He has effectively supported our strategic priorities in a complex market environment while maintaining disciplined capital management. His deep understanding of our business will continue to be instrumental as we advance our clinical pipeline, prepare for our Biologics License Application submission for CAN-2409 in localized prostate cancer, and execute on our near- and long-term corporate goals.' Since joining Candel in November 2021, Mr. Schoch has served in various financial reporting and accounting positions of increasing responsibility, most recently as VP of Finance and Corporate Controller, before being named interim CFO in January 2024. In his interim CFO role, Mr. Schoch developed significant investment banking relationships and has led the company through engagements with top-tier institutional investors, culminating in a previously-announced capital raise with net proceeds of approximately $86 million following the disclosure of positive results in the phase 3 clinical trial of CAN-2409 in localized prostate cancer in December 2024. In January 2025, he was promoted to Senior VP. During his time at Candel, Mr. Schoch has built a high-performing finance function that oversees Candel's financial close process, internal controls, SEC reporting, financial planning, procurement, payroll, and treasury operations. Mr. Schoch has also worked closely with Candel's executive leadership team on investor relations, business development, and financing initiatives. Prior to joining Candel, Mr. Schoch served as Corporate Controller at Corbus Pharmaceuticals from 2019 to 2021. Before Corbus, he spent seven years in PwC's Health Industry assurance practice where he served a diverse group of audit clients, ranging from pre-IPO to multinational public companies within the life sciences sector. Earlier in his career, Mr. Schoch worked for several Third Rock Venture portfolio companies as a financial and operational consultant. Mr. Schoch holds an M.B.A. and M.S.A. from Northeastern University and a B.S. in business administration with a concentration in finance from Elon University. 'I am honored to continue serving in this role and excited about the opportunities that lie ahead for Candel,' commented Mr. Schoch. 'Our strong financial foundation and disciplined approach to capital allocation and value creation position us well for sustainable growth. As we advance our promising clinical pipeline and prepare for key milestones, my focus remains on maintaining financial stability while strategically investing in our future. I look forward to working with our talented team on our goals of driving value for our stakeholders and ultimately helping to deliver clinically meaningful solutions to cancer patients in need.' About Candel Therapeutics Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform. The Company recently completed successful phase 2a clinical trials of CAN-2409 in non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and a pivotal phase 3 clinical trial of CAN-2409 in localized prostate cancer, conducted under a Special Protocol Assessment (SPA) agreed with the U.S. Food and Drug Administration (FDA). CAN-2409 plus prodrug (valacyclovir) has been granted Fast Track Designation by the FDA for the treatment of PDAC, stage III/IV NSCLC in patients who are resistant to first line PD-(L)1 inhibitor therapy and who do not have activating molecular driver mutations or have progressed on directed molecular therapy and localized primary prostate cancer. The FDA most recently also granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CAN-2409 for the treatment of newly diagnosed localized prostate cancer in patients with intermediate-to-high-risk disease and Orphan Drug Designation to CAN-2409 for the treatment of PDAC. CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing phase 1b clinical trial in recurrent high-grade glioma (rHGG). Initial results were published in Nature and CAN-3110 received Fast Track Designation and Orphan Drug Designation from the FDA. Finally, Candel's enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. For more information about Candel, visit: Forward-Looking Statements This press release includes certain disclosures that contain 'forward-looking statements,' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of current and future development programs, expectations regarding the submission of the BLA for CAN-2409 in intermediate-to-high-risk localized prostate cancer; and expectations regarding the therapeutic benefit of the Company's platforms, including the ability of its platforms to improve overall survival and/or disease-free survival of patients living with difficult to treat, solid tumors. The words 'may,' 'will,' 'could,' 'would,' 'should,' 'expect,' 'plan,' 'anticipate,' 'intend,' 'believe,' 'estimate,' 'predict,' 'project,' 'potential,' 'continue,' 'target' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; expectations regarding the therapeutic benefit of the Company's programs; that final data from the Company's preclinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; the Company's ability to efficiently discover and develop product candidates; the Company's ability to obtain and maintain regulatory approval of product candidates; the Company's ability to maintain its intellectual property; the implementation of the Company's business model, including strategic plans for the Company's business and product candidates; and other risks identified in the Company's filings with the U.S. Securities and Exchange Commission (SEC), including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, each as filed with the SEC and any subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company's views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Investor Contact: Theodore Jenkins VP, Investor Relations and Business Development Candel Therapeutics, Inc. tjenkins@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store